Overview

Drugs Brain and Behavior (DDP)

Status:
Recruiting

Trial end date:
2024-01-01

Target enrollment:

Participant gender:

Summary

In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Chicago

Treatments:

Methamphetamine